Résultats de la recherche - Brandon Carter‐Cooper
- Résultat(s) 1 - 2 résultats de 2
-
1
-
2
Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia par Ashkan Emadi, Rawan Faramand, Brandon Carter‐Cooper, Seda S. Tolu, Laurie Ford, Rena G. Lapidus, Meir Wetzler, Eunice S. Wang, Arash Etemadi, Elizabeth A. Griffiths
Publié 2015Artigo
Outils de recherche:
Sujets similaires
Biochemistry
Biology
Cancer research
Internal medicine
Medicine
Myeloid leukemia
Apoptosis
Azacitidine
Cancer
Cell biology
Cell growth
Chemistry
Chemotherapy
Cisplatin
DNA methylation
Dasatinib
Decitabine
Enzyme
Gastroenterology
Gene
Gene expression
Gene knockdown
Genetics
Head and neck cancer
Head and neck squamous-cell carcinoma
Hypomethylating agent
IDH1
IDH2
Imatinib
Isocitrate dehydrogenase